Prevalence of HLA-DQ Alleles and Haplotypes in Patients with Hepatitis B Infection
Objective: This study aimed to investigate whether HLA-DQA1 and HLA–DQB1 alleles and haplotypes are associated with progression of HBV infection to liver cirrhosis (LC) and hepatocellular carcinoma (HCC) in HBV infected patients. Methods: Genotyping of the HLA-DQ variants were carried out in 121 HBV patients (including 52 HBV without LC/HCC and 69 HBV with LC/HCC), using a polymerase chain reaction amplification with sequence specific oligonucleotide (PCR-SSO) technique and Luminex profiling system. Results: The two highest allele frequencies were seen for HLA-DQA1*01 and HLA-DQB1*03. A total of 66% of the HBV patients with LC/HCC and 62% of HBV patients without LC/HCC are carriers of HLA-DQA1*01 (p value= 0.908, OR= 0.95, CI= 0.41 - 2.10). As for HLA-DQB1*03, 73% of the HBV patients with LC/HCC and 60% of HBV patients without LC /HCC are carriers of this allele (p value= 0.320, OR= 1.56, CI= 0.65 - 3.72). In addition, 62% of HBV patients with LC/HCC (n=32) and 48% of HBV patients without LC/HCC (n=25) were carriers of haplotype DQA1*01-DQB1*05 (p value= 0.495, OR= 0.76, CI= 0.34 - 1.68). Conclusion: no association was seen between the HLA-DQA1 and the HLA–DQB1 alleles and haplotypes with HBV disease progression in the Malaysian population.
N. Posuwan, S. Payungporn, P. Tangkijvanich, S. Ogawa, S. Murakami, S. Iijima, et al., "Genetic Association of Human Leukocyte Antigens with Chronicity or Resolution of Hepatitis B Infection in Thai Population," PLOS ONE, vol. 9, p. e86007. 2014.
Z. Zeng, "Human genes involved in hepatitis B virus infection," World J Gastroenterol, vol. 20, pp. 7696-706, Jun. 2014.
R. Dhanasekaran, A. Limaye, and R. Cabrera, "Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics," Hepat Med, vol. 4, pp. 19-37, May. 2012.
Z. H. Lin, Y. N. Xin, Q. J. Dong, Q. Wang, X. J. Jiang, S. H. Zhan, et al., "Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma: a meta-analysis," BMC Gastroenterol, vol. 10, p. 145, Dec. 2010.
S. Tuncbilek, "Relationship between cytokine gene polymorphisms and chronic hepatitis B virus infection," World J Gastroenterol, vol. 20, pp. 6226-35, May. 2014.
J. M. Vierling, "The immunology of hepatitis B," Clin Liver Dis, vol. 11, pp. 727-59, vii-viii, Nov 2007.
M. Yue, K. Xu, M. P. Wu, Y. P. Han, P. Huang, Z. H. Peng, et al., "Human Leukocyte Antigen Class II Alleles Are Associated with Hepatitis C Virus Natural Susceptibility in the Chinese Population," Int J Mol Sci, vol. 16, pp. 16792-805, Jul. 2015.
J. M. Blackwell, S. E. Jamieson, and D. Burgner, "HLA and infectious diseases," Clin Microbiol Rev, vol. 22, pp. 370-85, Table of Contents, Apr. 2009.
J. H. Brown, T. S. Jardetzky, J. C. Gorga, L. J. Stern, R. G. Urban, J. L. Strominger, et al., "Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1," Nature, vol. 364, pp. 33-9, Jul.1993.
A. Godkin, M. Davenport, and A. V. Hill, "Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness," Hepatology, vol. 41, pp. 1383-90, Jun. 2005.
Y. N. Han, J. L. Yang, S. G. Zheng, Q. Tang, and W. Zhu, "Relationship of human leukocyte antigen class II genes with the susceptibility to hepatitis B virus infection and the response to interferon in HBV-infected patients," World J Gastroenterol, vol. 11, pp. 5721-4, Sep. 2005.
R. H. Chu, L. X. Ma, G. Wang, and L. H. Shao, "Influence of HLA-DRB1 alleles and HBV genotypes on interferon-alpha therapy for chronic hepatitis B," World J Gastroenterol, vol. 11, pp. 4753-7, Aug. 2005.
J. H. Kim, C. W. Pyo, D. K. Koh, J. K. Hur, J. H. Kang, and T. G. Kim, "Alteration of the influences of HLA classes I and II alleles on the perinatal hepatitis B virus infection after immunoprophylaxis in Korean children," Hepatol Res, vol. 35, pp. 118-26, Jun. 2006.
S. H. Ahn, K. H. Han, J. Y. Park, C. K. Lee, S. W. Kang, C. Y. Chon, et al., "Association between hepatitis B virus infection and HLA-DR type in Korea," Hepatology, vol. 31, pp. 1371-3, Jun. 2000.
P. Kummee, P. Tangkijvanich, Y. Poovorawan, and N. Hirankarn, "Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population," J Viral Hepat, vol. 14, pp. 841-8, Dec. 2007.
N. Nishida, H. Sawai, K. Kashiwase, M. Minami, M. Sugiyama, W. K. Seto, et al., "New susceptibility and resistance HLA-DP alleles to HBV-related diseases identified by a trans-ethnic association study in Asia," PLoS One, vol. 9, p. e86449, 2014.
J. B. Chook, Y. F. Ngeow, S. F. Yap, T. C. Tan, and R. Mohamed, "Combined use of wild-type HBV precore and high serum iron marker as a potential tool for the prediction of cirrhosis in chronic hepatitis B infection," J Med Virol, vol. 83, pp. 594-601, Apr. 2011.
J. Bruix and M. Sherman, "Management of hepatocellular carcinoma: an update," Hepatology, vol. 53, pp. 1020-2, Mar. 2011.
H. Mbarek, H. Ochi, Y. Urabe, V. Kumar, M. Kubo, N. Hosono, et al., "A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population," Hum Mol Genet, vol. 20, pp. 3884-92, Oct. 2011.
A. A. Al-Qahtani, M. R. Al-Anazi, A. A. Abdo, F. M. Sanai, W. Al-Hamoudi, K. A. Alswat, et al., "Association between HLA variations and chronic hepatitis B virus infection in Saudi Arabian patients," PLoS One, vol. 9, p. e80445, 2014.
M. K. Oliver and S. B. Piertney, "Selection maintains MHC diversity through a natural population bottleneck," Mol Biol Evol, vol. 29, pp. 1713-20, Jul. 2012.
Jiang, Wang, Liu, and Liu, "Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B," World J Gastroenterol, vol. 9, pp. 2221-5, Oct. 2003.
Thio, M. Carrington, D. Marti, S. J. O'Brien, D. Vlahov, K. E. Nelson, et al., "Class II HLA alleles and hepatitis B virus persistence in African Americans," J Infect Dis, vol. 179, pp. 1004-6, Apr. 1999.
Han, Yang, Zheng, Q. Tang, and W. Zhu, "Relationship of human leukocyte antigen class II genes with the susceptibility to hepatitis B virus infection and the response to interferon in HBV-infected patients," World J Gastroenterol, vol. 11, pp. 5721-4, Sep. 2005.
Z. Xi-Lin, D. Te, L. Jun-Hong, L. Liang-Ping, G. Xin-Hui, G. Ji-Rong, et al., "Analysis of HLA-DQB1 gene polymorphisms in asymptomatic HBV carriers and chronic hepatitis B patients in the Chinese Han population," Int J Immunogenet, vol. 33, pp. 249-54, Aug. 2006.
M. A. Karan, N. E. Tascioglu, A. O. Ozturk, S. Palanduz, and M. Carin, "The role of HLA antigens in chronic hepatitis B virus infection," J Pak Med Assoc, vol. 52, pp. 253-6, Jun. 2002.
L. Doganay, A. Fejzullahu, S. Katrinli, F. Yilmaz Enc, O. Ozturk, Y. Colak, et al., "Association of human leukocyte antigen DQB1 and DRB1 alleles with chronic hepatitis B," World Journal of Gastroenterology : WJG, vol. 20, pp. 8179-8186, 2014.
C. Liu and B. Cheng, "Association of polymorphisms of human leucocyte antigen-DQA1 and DQB1 alleles with chronic hepatitis B virus infection, liver cirrhosis and hepatocellular carcinoma in Chinese," Int J Immunogenet, vol. 34, pp. 373-8, Oct. 2007.
Y. N. Xin, Z. H. Lin, X. J. Jiang, S. H. Zhan, Q. J. Dong, Q. Wang, et al., "Specific HLA-DQB1 alleles associated with risk for development of hepatocellular carcinoma: a meta-analysis," World J Gastroenterol, vol. 17, pp. 2248-54, May. 2011.
- There are currently no refbacks.